These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37379329)

  • 1. Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin.
    Gambato S; Bellotto O; Mardirossian M; Di Stasi A; Gennaro R; Pacor S; Caporale A; Berti F; Scocchi M; Tossi A
    Bioconjug Chem; 2023 Jul; 34(7):1212-1220. PubMed ID: 37379329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.
    Mardirossian M; Barrière Q; Timchenko T; Müller C; Pacor S; Mergaert P; Scocchi M; Wilson DN
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.
    Sola R; Mardirossian M; Beckert B; Sanghez De Luna L; Prickett D; Tossi A; Wilson DN; Scocchi M
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the yjiL-mdtM Gene Cluster on the Antibacterial Activity of Proline-Rich Antimicrobial Peptides Overcoming Escherichia coli Resistance Induced by the Missing SbmA Transporter System.
    Krizsan A; Knappe D; Hoffmann R
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5992-8. PubMed ID: 26169420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
    Anderson SE; Sherman EX; Weiss DS; Rather PN
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity.
    Brakel A; Krizsan A; Itzenga R; Kraus CN; Otvos L; Hoffmann R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel Evolution of Tobramycin Resistance across Species and Environments.
    Scribner MR; Santos-Lopez A; Marshall CW; Deitrick C; Cooper VS
    mBio; 2020 May; 11(3):. PubMed ID: 32457248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.
    Bulitta JB; Ly NS; Landersdorfer CB; Wanigaratne NA; Velkov T; Yadav R; Oliver A; Martin L; Shin BS; Forrest A; Tsuji BT
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2315-27. PubMed ID: 25645838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome.
    Seefeldt AC; Graf M; Pérébaskine N; Nguyen F; Arenz S; Mardirossian M; Scocchi M; Wilson DN; Innis CA
    Nucleic Acids Res; 2016 Mar; 44(5):2429-38. PubMed ID: 26792896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Analysis of the Tobramycin and Gentamicin Clinical Resistome Reveals Limitations for Next-generation Aminoglycoside Design.
    Bassenden AV; Rodionov D; Shi K; Berghuis AM
    ACS Chem Biol; 2016 May; 11(5):1339-46. PubMed ID: 26900880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
    Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.
    Mardirossian M; Pérébaskine N; Benincasa M; Gambato S; Hofmann S; Huter P; Müller C; Hilpert K; Innis CA; Tossi A; Wilson DN
    Cell Chem Biol; 2018 May; 25(5):530-539.e7. PubMed ID: 29526712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of tobramycin, an aminoglycoside antibiotic.
    Dienstag J; Neu HC
    Antimicrob Agents Chemother; 1972 Jan; 1(1):41-5. PubMed ID: 4670427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the antimicrobial peptide Bac7 by deep mutational scanning.
    Koch P; Schmitt S; Heynisch A; Gumpinger A; Wüthrich I; Gysin M; Shcherbakov D; Hobbie SN; Panke S; Held M
    BMC Biol; 2022 May; 20(1):114. PubMed ID: 35578204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
    Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens.
    Mardirossian M; Sola R; Beckert B; Valencic E; Collis DWP; Borišek J; Armas F; Di Stasi A; Buchmann J; Syroegin EA; Polikanov YS; Magistrato A; Hilpert K; Wilson DN; Scocchi M
    J Med Chem; 2020 Sep; 63(17):9590-9602. PubMed ID: 32787108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
    Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.